News

BLP-003, currently being evaluated for treatment-resistant depression and alcohol use disorder, today announced their global phase 2b clinical trial has completed patient enrollment.

A recent study found that female physicians have a 53% higher risk of suicide compared with the female general population.

How do psychiatrists and mental health professionals respond when faced with disaster? One psychiatrist shares his story.

Pipeline drug BHV-7000 failed to meet primary endpoint in a pivotal phase 2/3 trial for bipolar disorder; meanwhile, BHV-1300 sees success in sustained Reductions in Total IgG.

Vincenzo Di Nicola has won the Award for Leadership in Child, Adolescent, and Young Adult Psychiatry. Learn more about his thoughts on trauma, leadership, and issues in child and adolescent psychiatry.

Let’s examine some current events related to sadness and joy.

Celebrate Psychiatric Times’ 40th anniversary with a look back at some of our previous covers.

Do you want to be featured in a future Special Report? Check out our March theme!

Check out 2 bite-sized reviews of books related to mental health.

Remembering 2 psychiatrists who emphasized the importance of work-life balance…

"Our findings provide a mechanistic explanation for the well-known variations in individual responses to drugs and suggest that subjective beliefs could be a direct target for the treatment of substance use disorders," said Xiaosi Gu, PhD, senior author of the study.

Learn more about recent research into adolescent mental health, including a pilot study testing the use of short-term trauma stabilization techniques with escitalopram.

The president of Black Psychiatrists of America shares his thoughts on making a difference for Black communities, the removal of the REMS for clozapine, and more.

Recap Psychiatric Times Black History Month coverage, including welcoming a new sports psychiatry section editor and a clinical conversation on using CBT to empower Black patients.

Here are highlights from this week in Psychiatric Times, including a special report on psychiatric symptoms of celiac disease and the potential dangers of cannabis use in older patients.

In this CME article, learn more about the opportunity for collaboration with dermatologist, psychologist, and social worker peers to improve patient mental health.

Check out the pipeline updates from February!

Learn more about the 5 principles of intervention that serve as guidance for developing practices after disasters and mass violence.

Remembering Alvin F. Poussaint, MD…

Newly shared top-line phase 4 data demonstrates clinically meaningful and sustained effects of Ingrezza capsules on the physical, social, and emotional impacts experienced with tardive dyskinesia.

A recent meta-analysis compares efficacy and acceptability of pharmacological, psychological, and neurostimulatory interventions for adults with ADHD.

The relationship between social media use and mental health remains inconclusive. How can you best treat child and adolescents and guide their social media use?

Can AI innovations assist in the process of creating the next DSM? One psychiatrist explains his thoughts.

"Connect me to all children, Under undue distress all ‘round the world, Shaping the future of our warring lands..."

How should clinicians approach treatment when their patient disagrees with the diagnosis?

According to research, symptoms of ADHD are more often overlooked or diagnosed later in children with higher cognitive ability, physical activity, or social skills.

Learn how best to facilitate catatonia assessment via telepsychiatry in this 3-case example article.

Could social media offer a new approach for clinicians working with patients experiencing some phobias?

The FDA has accepted the supplemental New Drug Application for Uzedy extended-release injectable suspension for the maintenance treatment of bipolar I disorder in adults.

How one resident found a free and accessible way to cope with her arachnophobia.